Skye Fishbein, PhD

Education

• Brandeis University, B.S./M.S.
• Harvard University, Ph.D.

Recognition

• K99/R00 Postdoctoral Scholar

Research Interests

• Ecology of the human gut microbiome
• Clostridioides difficile infection
• Bacterial genomics

Publications

Fishbein, SRS*, Deveaux A*, Khanna S*, Agee W, Ferreiro A, Liao J, Ning J, Mahmud B, Wallace M, Hink T, Reske K, Guruge J, Leekha S, Dubberke E, Dantas G. Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization. https://www.biorxiv.org/content/10.1101/2024.07.11.603094v2

Newcomer EP* and Fishbein SRS*, Zhang K, Hink T, Reske KA, Cass C, Iqbal ZH, Struttmann EL, Burnham CAD, Dubberke ER, Dantas G. Genomic surveillance of Clostridioides difficile transmission and virulence in a healthcare setting. mBio. 2024 Feb 8:e0330023. doi: 10.1128/mbio.03300-23. PMID: 38329369.

Fishbein, SRS* and Mahmud, B*, Dantas, G. Antibiotic perturbations to the gut microbiome. Nat. Rev Microbiol. 2023 Jul 25. doi: 10.1038/s41579-023-00933-y. PMID: 37491458

Fishbein SRS, Robinson JI, Hink T, Reske KA, Newcomer EP, Burnham CD, Henderson JP, Dubberke ER, Dantas G. Multi-omics investigation of Clostridioides difficile-colonized patients reveals pathogen and commensal correlates of C. difficile pathogenesis. Elife. 2022 Jan 27;11:e72801. doi: 10.7554/eLife.72801. PMID: 35083969; PMCID: PMC8794467.

Fishbein SRS, Hink T, Reske KA, Cass C, Struttmann E, Iqbal ZH, Seiler S, Kwon JH, Burnham CA, Dantas G, Dubberke ER. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients. mSphere. 2021 Jan 13;6(1):e00936-20. doi: 10.1128/mSphere.00936-20. PMID: 33441409; PMCID: PMC7845614.